[HTML][HTML] The angiopoietin/Tie2 pathway in hepatocellular carcinoma
B Vanderborght, S Lefere, HV Vlierberghe… - Cells, 2020 - mdpi.com
Due to the usually late diagnosis and lack of effective therapies, hepatocellular carcinoma
(HCC), which poses a growing global health problem, is characterized by a poor prognosis …
(HCC), which poses a growing global health problem, is characterized by a poor prognosis …
[HTML][HTML] The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
B Vanderborght, S Lefere, H Van Vlierberghe… - Cells, 2020 - ncbi.nlm.nih.gov
Due to the usually late diagnosis and lack of effective therapies, hepatocellular carcinoma
(HCC), which poses a growing global health problem, is characterized by a poor prognosis …
(HCC), which poses a growing global health problem, is characterized by a poor prognosis …
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
B Vanderborght, S Lefere, H Van Vlierberghe… - Cells, 2020 - cir.nii.ac.jp
抄録< jats: p> Due to the usually late diagnosis and lack of effective therapies,
hepatocellular carcinoma (HCC), which poses a growing global health problem, is …
hepatocellular carcinoma (HCC), which poses a growing global health problem, is …
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
B Vanderborght, S Lefere, H Van Vlierberghe… - Cells, 2020 - pubmed.ncbi.nlm.nih.gov
Due to the usually late diagnosis and lack of effective therapies, hepatocellular carcinoma
(HCC), which poses a growing global health problem, is characterized by a poor prognosis …
(HCC), which poses a growing global health problem, is characterized by a poor prognosis …
[PDF][PDF] The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
B Vanderborght, S Lefere, H Van Vlierberghe… - backoffice.biblio.ugent.be
Due to the usually late diagnosis and lack of effective therapies, hepatocellular carcinoma
(HCC), which poses a growing global health problem, is characterized by a poor prognosis …
(HCC), which poses a growing global health problem, is characterized by a poor prognosis …
The angiopoietin/tie2 pathway in hepatocellular carcinoma
B Vanderborght, S Lefere, H Van Vlierberghe… - CELLS, 2020 - biblio.ugent.be
Due to the usually late diagnosis and lack of effective therapies, hepatocellular carcinoma
(HCC), which poses a growing global health problem, is characterized by a poor prognosis …
(HCC), which poses a growing global health problem, is characterized by a poor prognosis …
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
B Vanderborght, S Lefere, H van Vlierberghe… - Cells, 2020 - go.gale.com
Due to the usually late diagnosis and lack of effective therapies, hepatocellular carcinoma
(HCC), which poses a growing global health problem, is characterized by a poor prognosis …
(HCC), which poses a growing global health problem, is characterized by a poor prognosis …
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma.
B Vanderborght, S Lefere, HV Vlierberghe… - Cells, 2020 - europepmc.org
Due to the usually late diagnosis and lack of effective therapies, hepatocellular carcinoma
(HCC), which poses a growing global health problem, is characterized by a poor prognosis …
(HCC), which poses a growing global health problem, is characterized by a poor prognosis …
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma.
B Vanderborght, S Lefere, HV Vlierberghe… - Cells (2073 …, 2020 - search.ebscohost.com
Due to the usually late diagnosis and lack of effective therapies, hepatocellular carcinoma
(HCC), which poses a growing global health problem, is characterized by a poor prognosis …
(HCC), which poses a growing global health problem, is characterized by a poor prognosis …
[引用][C] The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
B Vanderborght, S Lefere, HV Vlierberghe… - Cells (Web), 2020 - jglobal.jst.go.jp
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma | Article Information | J-GLOBAL
Art J-GLOBAL ID:202102265661435560 Reference number:21A0828275 The Angiopoietin/Tie2 …
Art J-GLOBAL ID:202102265661435560 Reference number:21A0828275 The Angiopoietin/Tie2 …